Oncology

HR+/HER2- Early Breast Cancer

Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at SABCS 2025

conference reporter by Erica L. Mayer, MD, MPH; Seth A. Wander, MD, PhD

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Early Breast Cancer presented at the San Antonio Breast Cancer Symposium 2025.

VIEW THE TOPICS:

Adjuvant Therapy for Early-Stage HR+/HER2- Breast Cancer
Precision Medicine in Early-Stage HR+/HER2- Breast Cancer
SABCS 2025 Highlights and Early-Stage HR+/HER2- Breast Cancer
Treatment Options for Stage III HR+/HER2- Breast Cancer

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the San Antonio Breast Cancer Symposium.

SABCS 2025

December 9– December 13, 2025

Henry B. Gonzalez Convention Center, San Antonio, Tx & Online

Link to Registration

Profile

Erica L. Mayer, MD, MPH

Director of Breast Cancer Clinical Research
Breast Oncology Center
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Profile

Seth A. Wander, MD, PhD

Director of Translational Research, Breast Oncology Program
Massachusetts General Hospital
Director of Precision Medicine, Henri and Belinda Termeer Center for Targeted Therapies
Mass General Brigham Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Boston, MA

Oncology

HR+/HER2- Early Breast Cancer

Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at SABCS 2025

Erica L. Mayer, MD, MPH

Seth A. Wander, MD, PhD

Explore More in HR+/HER2- Early Breast Cancer

Breast Cancer Risk Assessment and Reduction Strategies

Expert Perspectives® in HR+/HER2- Early Breast Cancer to Cover Key Topics in HR+/HER2- Early Breast Cancer Treatment